57 related articles for article (PubMed ID: 38659420)
1. Bioinformatics analysis and experimental verification of NLRX1 as a prognostic factor for esophageal squamous cell carcinoma.
Zhou L; Gan L; Sun C; Chu A; Yang M; Liu Z
Oncol Lett; 2024 Jun; 27(6):264. PubMed ID: 38659420
[TBL] [Abstract][Full Text] [Related]
2.
Zheng Y; Luo M; Lü M; Zhou T; Liu F; Guo X; Zhang J; Kang M
Onco Targets Ther; 2020; 13():11193-11209. PubMed ID: 33173311
[TBL] [Abstract][Full Text] [Related]
3. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
4. NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells.
Hu B; Ding GY; Fu PY; Zhu XD; Ji Y; Shi GM; Shen YH; Cai JB; Yang Z; Zhou J; Fan J; Sun HC; Kuang M; Huang C
J Hematol Oncol; 2018 Feb; 11(1):28. PubMed ID: 29482578
[TBL] [Abstract][Full Text] [Related]
5. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
[TBL] [Abstract][Full Text] [Related]
6. Protein Arginine Methyltransferase 5 Promotes Esophageal Squamous Cell Carcinoma Proliferation and Metastasis via LKB1/AMPK/mTOR Signaling Pathway.
Chen YR; Li HN; Zhang LJ; Zhang C; He JG
Front Bioeng Biotechnol; 2021; 9():645375. PubMed ID: 34124017
[No Abstract] [Full Text] [Related]
7. Expression and prognostic value of AIM1L in esophageal squamous cell carcinoma.
Zhou L; Gan L; Liu Z
Medicine (Baltimore); 2023 Aug; 102(34):e34677. PubMed ID: 37653730
[TBL] [Abstract][Full Text] [Related]
8. NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells.
Nagai-Singer MA; Morrison HA; Woolls MK; Leedy K; Imran KM; Tupik JD; Allen IC
Front Oncol; 2023; 13():1155831. PubMed ID: 37342194
[TBL] [Abstract][Full Text] [Related]
9. The generation, activation, and polarization of monocyte-derived macrophages in human malignancies.
Chaintreuil P; Kerreneur E; Bourgoin M; Savy C; Favreau C; Robert G; Jacquel A; Auberger P
Front Immunol; 2023; 14():1178337. PubMed ID: 37143666
[TBL] [Abstract][Full Text] [Related]
10. Identification of immune related gene signature for predicting prognosis of cholangiocarcinoma patients.
Zhang ZJ; Huang YP; Liu ZT; Wang YX; Zhou H; Hou KX; Tang JW; Xiong L; Wen Y; Huang SF
Front Immunol; 2023; 14():1028404. PubMed ID: 36817485
[TBL] [Abstract][Full Text] [Related]
11. Research Progress on the Predicting Factors and Coping Strategies for Postoperative Recurrence of Esophageal Cancer.
Zhang Y; Zhang Y; Peng L; Zhang L
Cells; 2022 Dec; 12(1):. PubMed ID: 36611908
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Novel GRHL3/HOPX/Wnt/β-Catenin Proto-oncogenic Axis in Squamous Cell Carcinoma of the Esophagus.
Georgy SR; Rudiatmoko DR; Auden A; Partridge D; Butt T; Srivastava S; Wong N; Swaroop D; Carpinelli MR; Yan F; Bogeski M; Jane SM
Cell Mol Gastroenterol Hepatol; 2023; 15(5):1051-1069. PubMed ID: 36442813
[TBL] [Abstract][Full Text] [Related]
13.
Hu N; Wang C; Zhang T; Su H; Liu H; Yang HH; Giffen C; Hu Y; Taylor PR; Goldstein AM
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291785
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
